|
| General strategy | examples | HO related phenotypes? | references |
|
Animal models of hereditary HO | Hyperactive BMP receptor | ACVR1(R206H) mutation into zebrafish | No HO | [20] |
Conditionally expresses caALK2 in mice | Embryonic lethal, no HO | [29] |
Knocking out BMP inhibitors | Noggin-/- mice | Postnatal lethal, skeletal defects, HO? | [30] |
Chordin-/- mice | Postnatal lethal, skeletal defects | [31] |
Overexpressing BMPs | K14-BMP4 | No HO | [32] |
Msx1-BMP4 | No observable defects | [33] |
Nse-BMP4 | Progressive HO, FOP-like | [34] |
Overexpressing BMP target genes | CMV-MSX2, TIMPl-MSX2 or MSX2-MSX2 | HO-like | [35] |
col2-Runx2 | HO-like | [36] |
Modifying BMP signaling indirectly | H2FosLTR-Fos | Calcified tumors similar to HO | [37] |
Fos-ES cell chimeras | Chondrosarcomas, similar to HO | [38] |
|
Animal models of acquired HO | Heterotopic implantation | BMP matrigel implantation | HO | [39] |
DNA construct that produces BMPs | HO | [40] |
Nanogel-cross-linking hydrogel as a scaffold | HO | [41] |
Bone marrow cells | HO | [42] |
Microporous calcium phosphate ceramic | HO | [43] |
Hip arthroplasty model | Hip arthroplasty in rabbits | HO | [44] |
Michelsson model | Immobilization manipulation in rabbits | HO | [45] |
Achilles tenotomy model | Achilles tenotomy in rats | HO | [46] |
Trauma-induced model | Blunt force in rabbit thigh | No HO | [47] |
Repeated blunt force in sheep thigh | HO in small % of treated animals | [48] |
Inject irritants and other materials | Injection of 40% ethanol | HO | [49] |
Injection of acid-alcohol | HO in small % of treated animals | [50] |
|